S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.83 (-11.75%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)
S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.83 (-11.75%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)
S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.83 (-11.75%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)
S&P 500   5,255.31 (+0.13%)
DOW   39,786.30 (+0.07%)
QQQ   444.83 (+0.00%)
AAPL   171.23 (-1.20%)
MSFT   420.96 (-0.11%)
META   489.18 (-0.95%)
GOOGL   150.88 (+0.01%)
AMZN   180.63 (+0.44%)
TSLA   177.44 (-1.33%)
NVDA   908.62 (+0.68%)
NIO   4.70 (+0.64%)
AMD   181.47 (+1.05%)
BABA   72.30 (+0.99%)
T   17.61 (+0.34%)
F   13.22 (+1.23%)
MU   118.98 (-0.13%)
CGC   8.91 (-6.70%)
GE   177.09 (-1.68%)
DIS   122.56 (+1.31%)
AMC   3.83 (-11.75%)
PFE   27.87 (+0.32%)
PYPL   66.77 (+0.30%)
XOM   115.34 (+0.32%)

Quipt Home Medical (QIPT) Stock Price, News & Analysis

$4.37
+0.03 (+0.69%)
(As of 09:52 AM ET)
Today's Range
$4.32
$4.39
50-Day Range
$4.03
$4.97
52-Week Range
$3.90
$7.26
Volume
7,424 shs
Average Volume
134,517 shs
Market Capitalization
$183.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

Quipt Home Medical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
130.4% Upside
$10.00 Price Target
Short Interest
Bearish
1.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.89mentions of Quipt Home Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
225.00%
From $0.04 to $0.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.83 out of 5 stars

Medical Sector

689th out of 939 stocks

Surgical & Medical Instruments Industry

73rd out of 98 stocks

QIPT stock logo

About Quipt Home Medical Stock (NASDAQ:QIPT)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

QIPT Stock Price History

QIPT Stock News Headlines

QIPT Apr 2024 10.000 call
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Quipt Home Medical just downgraded at Raymond James, here's why
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Canadian CPI Due Next Week
Quipt Home Medical (QIPT) Receives a Buy from M Partners
Quipt Home Medical (QIPT) Receives a Buy from Benchmark Co.
See More Headlines
Receive QIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Today
3/28/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:QIPT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.00
High Stock Price Target
$10.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+130.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-2,780,000.00
Pretax Margin
-1.51%

Debt

Sales & Book Value

Annual Sales
$221.74 million
Cash Flow
$0.89 per share
Book Value
$2.64 per share

Miscellaneous

Free Float
40,334,000
Market Cap
$182.71 million
Optionable
Optionable
Beta
0.60
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Gregory J. Crawford
    Chairman, President & CEO
  • Mr. Hardik Mehta
    Chief Financial Officer
  • Mr. David Bachelder
    Executive Vice President of Operations
  • Mr. William Todd Zehnder (Age 49)
    Chief Strategy Officer & Investor Relations
    Comp: $308.24k
  • Cole Stevens
    VP of Corporate Development & VP of Investor Relations
  • Mr. Mark Miles
    Vice President of Information Technology
  • Mr. Thomas W. Roehrig (Age 58)
    Executive Vice President of Finance
  • Mr. Robert Grossman LLB (Age 50)
    Corporate Secretary

QIPT Stock Analysis - Frequently Asked Questions

Should I buy or sell Quipt Home Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Quipt Home Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" QIPT shares.
View QIPT analyst ratings
or view top-rated stocks.

What is Quipt Home Medical's stock price target for 2024?

2 Wall Street analysts have issued 1 year price objectives for Quipt Home Medical's shares. Their QIPT share price targets range from $10.00 to $10.00. On average, they expect the company's share price to reach $10.00 in the next year. This suggests a possible upside of 130.4% from the stock's current price.
View analysts price targets for QIPT
or view top-rated stocks among Wall Street analysts.

How have QIPT shares performed in 2024?

Quipt Home Medical's stock was trading at $5.09 at the start of the year. Since then, QIPT shares have decreased by 14.7% and is now trading at $4.34.
View the best growth stocks for 2024 here
.

When is Quipt Home Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our QIPT earnings forecast
.

How were Quipt Home Medical's earnings last quarter?

Quipt Home Medical Corp. (NASDAQ:QIPT) issued its quarterly earnings data on Wednesday, February, 14th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.02. The firm had revenue of $65.36 million for the quarter, compared to analyst estimates of $63.43 million. Quipt Home Medical had a negative trailing twelve-month return on equity of 3.57% and a negative net margin of 1.50%.

Who are Quipt Home Medical's major shareholders?

Quipt Home Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include NewGen Asset Management Ltd (1.96%), Putnam Investments LLC (1.69%), First Eagle Investment Management LLC (1.66%), Boston Partners (1.56%), Russell Investments Group Ltd. (1.19%) and Vanguard Group Inc. (0.57%).

How do I buy shares of Quipt Home Medical?

Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:QIPT) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners